May 4, 2016

 

Via EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attn: Suzanne Hayes
   
Re: Oncobiologics, Inc.
  Registration Statement on Form S-1
  File No. 333-209011

 

  Acceleration Request  
  Requested Date: May 5, 2016
  Requested Time: 4:00 p.m., Eastern Time

 

Ladies and gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Jefferies LLC and Barclays Capital Inc., as representatives of the several underwriters, hereby join Oncobiologics, Inc. in requesting that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-209011) to become effective on Thursday, May 5, 2016, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter.

 

Additionally, pursuant to Rule 460 of the Act, we hereby advise you that the Preliminary Prospectus dated April 27, 2016, was distributed by us, as representatives of the several underwriters, approximately as follows from April 27, 2016 through the date hereof:

 

Copies to underwriters 661
Copies to dealers 0
Copies to institutional investors 588
Copies to others/retail 5
Total 1,254

 

We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.

 

Very truly yours,

 

JEFFERIES LLC

BARCLAYS CAPITAL INC.,

As Representatives

 

[Signature Page Follows]

 

 

 

 

  JEFFERIES LLC
     
  By: /s/ Matthew Kim
    Name: Matthew Kim
    Title:   Managing Director
     
  BARCLAYS CAPITAL INC.
     
  By: /s/ Victoria Hale
    Name: Victoria Hale
    Title:   Vice President

 

cc: Pankaj Mohan, Ph.D., Oncobiologics, Inc.
  Lawrence A. Kenyon, Oncobiologics, Inc.
  Stuart M. Cable, Goodwin Procter LLP
  Edwin O’Connor, Goodwin Procter LLP
  Seo Salimi, Goodwin Procter LLP
  Yvan-Claude Pierre, Cooley LLP
  Daniel I. Goldberg, Cooley LLP
  Marianne Sarrazin, Cooley LLP

 

[signature page to acceleration request letter]